Why Aurora Cannabis Stock Lost Half of Its Value in September

What happened Shares of Aurora Cannabis (NYSE:ACB), a top Canadian marijuana company, lost a jaw-dropping 50% of their value during the month of September, according to data provided by S&P Global Market Intelligence. The pot titan’s market cap tanked for four interrelated reasons: The company announced an eye-popping 1.8 billion ... Read More

Will Pot Stock Aurora Cannabis Ever Be Worth Buying?

Though all eyes have been on the fast-growing tech sector for much of 2020, don’t overlook the sleeping giant in North America: Cannabis. After turning in just shy of $11 billion in global sales in 2018, Wall Street estimates suggest that worldwide legal weed revenue could hit $50 billion to ... Read More

Legalize Marijuana Market 2020 Insights and Global Outlook | Cronos Group, Canopy Growth, Aurora Cannabis, ABcann Medicinals

The MarketWatch News Department was not involved in the creation of this content. Oct 06, 2020 (Market Insight Reports) — The Global Legalize Marijuana Market Research Report 2020-2026 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic ... Read More

Aurora Cannabis Stock: Love It or Leave It?

Canadian marijuana company Aurora Cannabis (NYSE:ACB) had a dreadful 2019; its stock lost 56% of its value over the year, compared with a 36% decline in the industry benchmark Horizons Marijuana Life Sciences ETF. External headwinds in Canada, along with Aurora’s own haphazard acquisitions, dragged down revenue and made profit ... Read More

Should You Buy or Sell Aurora Cannabis Now?

Aurora Cannabis (NYSE:ACB) released its fourth-quarter results on Sept. 22 and they were yet another disappointment, with the company reporting a loss of 1.9 billion Canadian dollars for the period as impairment charges of CA$1.8 billion weighed heavily on its financials. Net revenue of CA$72.1 million also came in lower than ... Read More